Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Brazil / NCT05653206
Active, not recruiting Observational

Incomplete Cervical SCI Without Instability

NCT05653206 · tracked via the Priya Life Science Brazil tracker
Phase
Observational
Started
2023-12-11
Last updated
2026-02-24

Condition(s) studied

Cervical Spinal Cord Injury

Investigational drug(s) / intervention(s)

Nonsurgical treatmentSurgical treatment

Nonsurgical treatment: Cervical collar, Halo ring, Halo vest, cervical braces, skeletal skull traction, MAP, steroids, observation or bedrest

Surgical treatment: Anterior discectomy and instrumented fusion (single level), Anterior discectomy and instrumented fusion (multi-level), Posterior decompression-laminectomy, Posterior decompression-laminoplasty, Posterior decompression and instrumented fusion, Combined anterior and posterior decompression and instrumented fusion

Study summary

A multicenter, international, prospective, observational case series patient cohort with incomplete cervical SCI without instability will be enrolled to obtain information and data that could inform the feasibility of administering a set of additional core and optional outcome assessments in cervical SCI patients to capture the aspects of neurologic impairment. Baseline, intraoperative, and postoperative characteristics, including demographics, injury details, treatment details, neurological assessments, gait and balance assessments and upper extremity assessments, will be recorded for adult patients.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * Age 18-80 years, inclusive * Diagnosis of acute traumatic cervical SCI with ISNCSCI AIS Grade D or sensory deficits only within 92 hours post injury * Cervical neurological level of injury (C2-C8) * MRI, using any imaging protocols (conventional, multiparametric, or quantitative), taken according to standard of care * Presence of spinal cord compression on the MRI * Absence of biomechanical instability to the extent that would mandate stabilization surgery by the treating surgeon * Ability to provide informed consent according to the IRB/EC defined and approved procedures Exclusion Criteria: * Nontraumatic SCI * Concomitant traumatic brain injury or polytrauma that could preclude accurate or reliable assessments of the outcome assessments * Uncontrolled severe systemic diseases, preexisting neurological, musculoskeletal, or general medical conditions which could preclude accurate assessments or FUs * Individuals unable to undergo MRI

Primary outcome measure(s)

Trial sites (10)

FacilityCityRegionStatus
San Francisco General Hospital San Francisco California
UMD STC Neurosurgery Clinic Baltimore Maryland
Medical college of Winsconsine, Neurosurgery Milwaukee Wisconsin
Instituto de Ortopedia E Traumatologia Do Hospital Das Clinicas Da Universidade de Sao Paulo São Paulo Brazil
St. Michael's Hospital Toronto Canada
Toronto Western Hospital University Health Network Toronto Canada
Vancouver Spine Research Program, Blusson Spinal Cord Centre Vancouver Canada
BG Klinikum Murnau gGmb, BGU Murnau, Trauma Center Murnau Murnau am Staffelsee Germany
Indian Spinal Injuries Centre New Delhi India
Orthopaedics, Centro Hospitalar Universitário do Porto Porto Portugal

More AO Foundation, AO Spine trials in Brazil

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05653206 on ClinicalTrials.gov ↗ ← All trials in Brazil